Tricordatine | 51076-20-1

• 分子结构分类: 有机化合物 - 木脂素、新木脂素和相关化合物
• 英文名称: Tricordatine
• 英文别名: 7,22-dimethyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.216,19.14,30.110,14.03,8.025,33.028,32]heptatriaconta-1(30),2,4(34),10(37),11,13,16,18,25,27,32,35-dodecaene-13,27-diol
• CAS: 51076-20-1
• 化学式: C₃₄H₃₂N₂O₅
• 分子量: 548.6
• InChiKey: ZMFKWCVOCDSEST-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  41
• 可旋转键数：
  0
• 环数：
  9.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• TRILOBINE DERIVATIVES AND THEIR USE THEREOF IN THE TREATMENT OF MALARIA
  申请人：Institut Pasteur

  公开号：EP3907227A1

  公开（公告）日：2021-11-10

  The present invention is in the field of therapeutic drugs to treat malaria. In particular, the invention provides trilobine derivatives per se, and trilobine derivatives for use in the treatment of malaria, for example drug-resistant malaria.

  本发明属于治疗药物领域，用于治疗疟疾。具体而言，本发明提供三叶草碱衍生物本身，以及用于治疗疟疾的三叶草碱衍生物，例如用于治疗药物耐药性疟疾。
• Cytokine receptor
  申请人：Varghese Noozhumutry Joseph

  公开号：US20070032640A1

  公开（公告）日：2007-02-08

  A crystalline composition comprising a crystal of the IL-6 receptor I chain is provided. Also provided are methods of using the crystal and related structural information to screen for and design compounds that interact with IL-6R, or variants thereof. Also provided arc methods of modulating an IL-6 receptor comprising contacting the IL-6 receptor with a compound identified by the screening method of the invention.
• [EN] TRILOBINE DERIVATIVES AND THEIR USE THEREOF IN THE TREATMENT OF MALARIA<br/>[FR] DÉRIVÉS DE TRILOBINE ET LEUR UTILISATION DANS LE TRAITEMENT DU PALUDISME
  申请人：PASTEUR INSTITUT

  公开号：WO2021224491A1

  公开（公告）日：2021-11-11

  The present invention is in the field of therapeutic drugs to treat malaria. In particular, the invention provides trilobine derivatives per se, and trilobine derivatives for use in the treatment of malaria, for example drug-resistant malaria.